Follow along with the video below to see how to install our site as a web app on your home screen.
Note: this_feature_currently_requires_accessing_site_using_safari
That last paragraph you wrote is what the media is failing to bring to people’s knowledge. The laymen hear 95%, 76% of efficacy but they don’t get the second part of the sentence which is efficacy against severe and lethal forms! I personally know 3 healthcare professionals who had both COVID-19 and were immunized then had a second episode of Covid-19 (luckily all 3 had very mild forms the second time).WHO reviewing Seychelles data after fully vaccinated get COVID
https://www.aljazeera.com/news/2021...chelles-data-after-fully-vaccinated-get-covid
12 May 2021
"Country’s health ministry says a third of those diagnosed with COVID-19 in past week had had both doses of vaccine...
The WHO has said a large Phase III trial of Sinopharm has shown that two doses, administered at an interval of 21 days, have an efficacy of 79 percent against symptomatic infection, 14 or more days after the second dose. AstraZeneca said in March its COVID-19 vaccine was 76-percent effective...."
That last paragraph you wrote is what the media is failing to bring to people’s knowledge. The laymen hear 95%, 76% of efficacy but they don’t get the second part of the sentence which is efficacy against severe and lethal forms! I personally know 3 healthcare professionals who had both COVID-19 and were immunized then had a second episode of Covid-19 (luckily all 3 had very mild forms the second time).
So yes, people look at what is happening in England at a country level and think they can apply it to their little selves.
It will become endemic/seasonal like any other flu virus...Bottom line as I stated way earlier, it's here to stay, in what form is entirely up to us, it will become endemic.
South Africa’s most vaccine-hesitant people speak Afrikaans, a new study says
https://www.businessinsider.co.za/s...eople-speak-afrikaans-a-new-study-says-2021-5
12 May 2021
The majority of South Africans are increasingly eager to receive their jabs, suggests the latest NIDS-CRAM survey, which asked more than 5,600 interviewees if they would get a Covid-19 vaccination. More than half of the respondents (55%) "strongly agreed" to receiving the vaccine, while 16% "somewhat agreed"...
- The latest NIDS-CRAM survey shows that 29% of South Africans are hesitant about getting Covid-19 jabs.
- Hesitancy rates are generally down from previous reports.
- More than a third of respondents aged between 18 and 24 said they were hesitant to get a Covid-19 vaccine.
- And fewer than 60% of Afrikaans-speaking respondents indicated their willingness to be innoculated, especially in the Northern and Western Cape.
The NIDS-CRAM Wave 4 survey, conducted between 2 February and 10 March 2021, has identified hesitancy rates according to age, gender, population group, home language, geography, and level of education.
Among the 29% of respondents who are vaccine hesitant, almost a third cited concerns about the jab's side-effects as a primary reason for being wary. Just over 20% of vaccine hesitant respondents worried about the vaccine’s effectiveness, and 18% reported "being against vaccines in general."
Other concerns include uncertainty about the safety of the vaccine (14%), lack of trust in government (2%), affordability, and time (both 1%).
Of all the age groups surveyed, 37% of respondents aged between 18 and 24 said they were hesitant to get vaccinated against Covid-19, significantly higher than the national average of 29%.
Respondents over the age of 60 are most willing to be vaccinated (72.8%).
And while the NIDS-CRAM study found no clear correlation between hesitancy or willingness rates and socioeconomic status, evidence points to levels of education playing a role in the acceptance of vaccines. Respondents with only primary schooling are more likely to be vaccine hesitant, while more than 75% of those with a tertiary education indicated that they are willing to take the jab.
Other statistically significant differences were recorded among diverse population groups and home language speakers, where coloured and Afrikaans-speaking South Africans ranked as the most vaccine hesitant, respectively.
"We find that 42% of Afrikaans home language respondents were vaccine hesitant, much higher than the national average [29%] and if we use a 90% significance threshold, the mean for Afrikaans speakers are significantly higher than 7 of the 11 language groups," the Wave 4 presentation notes.
"Although NIDS-CRAM is not provincially representative, in light of the language results and the predominance of Afrikaans in the Western Cape and Northern Cape, it is also clear that respondents from these provinces had higher vaccine hesitancy on average."
Of the respondents with Sesotho as their home language, 35% indicated that they are vaccine hesitant. A third of all English respondents also indicated hesitancy.
Vaccine hesitancy rates among isiXhosa and isiZulu speakers matched, with a quarter of respondents indicating their wariness. Tshivenda speakers had the lowest hesitancy rates of just 18%.
"Taken together, these language and provincial results suggest that campaigns targeted at both of these provinces and at Afrikaans' home language speakers is supported by this data," adds NIDS-CRAM.
In terms of hesitancy rates among different population groups, NIDS-CRAM found that black South Africans were most willing (73%) to be vaccinated against Covid-19, while coloured South Africans were the most hesitant, with just 57.6% of respondents indicating their willingness..."
Just under 61% of Indian and Asian respondents indicated that they were willing to receive their jabs. Of all white respondents, 65% indicated they would accept a Covid-19 vaccine if it were available.